Skip to main content
BIP logo

April 02, 2019

Internal newsletter of the Institut Pasteur

Institut Pasteur
  • Français
  • English
News

Discovery of a restriction factor for hepatitis B virus

Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not curative for infected individuals. Scientists at the Institut Pasteur working in collaboration with the CNRS have demonstrated that a cellular protein is capable of acting as a restriction factor for the hepatitis B virus by degrading the viral DNA.

Find out more

<<< Retour
  • BIP Archives
  • Contact